Sera Prognostics GAAP EPS of -$0.20 beats by $0.01, revenue of $0.03M misses by $0.03M
Source: SeekingAlpha
2025-05-07 16:14:55 ET
More on Sera Prognostics
- Sera Prognostics: Initiating With Hold, Potential Of PreTRM Test, But Uncertain Commercial Timeline
- Sera Prognostics Inc (SERA) Q4 2024 Earnings Call Transcript
- Sera Prognostics dips 5%, prices $50M offering
- Sera Prognostics announces proposed public offering
- Seeking Alpha’s Quant Rating on Sera Prognostics
Read the full article on Seeking Alpha
For further details see:
Sera Prognostics GAAP EPS of -$0.20 beats by $0.01, revenue of $0.03M misses by $0.03M
Sera Prognostics Inc.
NASDAQ: SERA
SERA Trading
3.85% G/L:
$2.16 Last:
28,768 Volume:
$2.03 Open:
SERA Latest News
March 04, 2026 08:05:00 am
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026
February 17, 2026 08:05:00 am
SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE
January 07, 2026 08:30:00 am
Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications
SERA Stock Data
$102,276,201
30,181,128
0.21%
28
N/A
Medical Diagnostics & Screening
Healthcare
US
Salt Lake City
